Fig. 1From: Antimicrobial susceptibility among gram-positive and gram-negative blood-borne pathogens collected between 2012-2016 as part of the Tigecycline Evaluation and Surveillance TrialDistribution of multi-drug resistant (MDR) bacteria among isolates from blood specimen collected in various international regions. Percent on every column indicates percentage of resistant isolates in each region for each organism. ESBL, extended-spectrum β-lactamase; CARB-NS, cabapanem non-susceptibility; MRSA, methicillin-resistant S. aureus; VR, vancomycin resistant; PRSP, Penicillin-resistant S. pneumoniaeBack to article page